Published by
@ShahidNShah
@ShahidNShah
July 9 to July 11, 2024
The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States
The 3rd In Vivo Cell Engineering and Gene Editing Summit is scheduled from July 9th to 11th, 2024, marking a pivotal moment as in vivo cell engineering and gene editing transitions from theoretical concept to tangible clinical reality. By uniting leading experts, this summit offers a unique opportunity to explore every aspect of development in this frontier of cell and gene therapies. Executives, VPs, and Directors from Discovery, Pre-Clinical, and Translational fields convene to showcase approaches, address uncertainties, and propel pipelines forward. With contributions from industry titans like Capstan Therapeutics and Editas Medicine, the agenda promises unparalleled insights, shaping the future of cell and gene therapy.
[Read on in-vivo-engineering.com](https://in-vivo-engineering.com/take-part/register/)
Continue reading at in-vivo-engineering.com
July 10 to July 12, 2024
The Westin Copley Place, Boston, 10 Huntington Avenue, Boston, Massachusetts, 02116, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 18, 2024 at 12:33pm